Cargando…

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease

Detalles Bibliográficos
Autores principales:	Sampaio, Elieusa e Silva, Oliveira, Márcia Maria Carneiro, Aras, Roque
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898783/ https://www.ncbi.nlm.nih.gov/pubmed/29694544 http://dx.doi.org/10.5935/abc.20180029

Ejemplares similares

Incidence of Atrial High-Rate Episodes in Chagas Disease Patients
por: Freitas, Emanoela Lima, et al.
Publicado: (2018)

Therapeutic Adherence and Functional Capacity in Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2015)

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2018)

Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction?
por: Hammer, Andreas, et al.
Publicado: (2023)

Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
por: Xanthopoulos, Andrew, et al.
Publicado: (2022)

Methodological problems in the measurement of interleukin-33 concentrations in patients with heart failure with a reduced ejection fraction
por: Keskin, Berhan, et al.
Publicado: (2019)

Fragmented QRS and Chagas' disease
por: Baranchuk, Adrian
Publicado: (2014)

Physician Awareness of Chagas Disease, USA
por: Stimpert, Kelly K., et al.
Publicado: (2010)

Dexmedetomidine in upper gastrointestinal endoscopy of a patient with ejection fraction 25%
por: Srivastava, Divya, et al.
Publicado: (2014)

Cardiac volumes and left ventricular ejection fraction on myocardial perfusion scintigraphy
por: Lee, Joseph C., et al.
Publicado: (2020)

Episódios de Alta Frequência Atrial e sua Associação com Eventos Isquêmicos Cerebrais em Pacientes Chagásicos
por: Freitas, Emanoela Lima, et al.
Publicado: (2020)

Chagas Disease in Ancient Hunter-Gatherer Population, Brazil
por: Lima, Valdirene S., et al.
Publicado: (2008)

Let's reduce the blood volume collected for laboratorial exams?
por: Carneiro-Sampaio, Magda, et al.
Publicado: (2014)

Catheter Ablation for Atrial Fibrillation Targeting Incremental Left Ventricular Ejection Fraction
por: Chapman, Mimi, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction: A distinct heart failure phenotype?
por: Triposkiadis, Filippos, et al.
Publicado: (2022)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

Direct economic impact of Chagas disease treatment
por: Zaidel, Ezequiel J., et al.
Publicado: (2022)

Long-Term Outcomes of Heart Failure Patients With Preserved, Mildly Reduced, and Reduced Ejection Fraction
por: Nagata, Takuya, et al.
Publicado: (2023)

Subclinical Atherosclerosis in Patients with Chronic Non-Dialytic Renal Disease
por: Borges, Wagner Ramos, et al.
Publicado: (2015)

Cause of Death Among Patients With Diabetes and Heart Failure With Reduced Ejection Fraction
por: Sharma, Abhinav, et al.
Publicado: (2022)

Cheyne‐stokes respiration associated with hypertrophic cardiomyopathy and normal left ventricular ejection fraction
por: Pedrosa, Rodrigo P, et al.
Publicado: (2010)

Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
por: Schäfer, Andreas, et al.
Publicado: (2021)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

Mortality Rate of Sepsis Patients in the Intensive Care Unit: The Prognostic Role of Ejection Fraction and Procalcitonin
por: Hejazi, Mohammad Esmaeil, et al.
Publicado: (2021)

Vericiguat for Heart Failure with Reduced Ejection Fraction
por: Lombardi, Carlo Mario, et al.
Publicado: (2021)

Cord Blood Sample Screening for Evidence of Maternal Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2017)

Addressing the Challenge of Atrial Fibrillation Management: How to Differentiate the Approach Depending on Left Ventricular Ejection Fraction
por: De Vecchis, Renato, et al.
Publicado: (2019)

Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly
por: TIAN, Zhuang, et al.
Publicado: (2020)

Reply to ‘Heart failure with preserved ejection fraction and COVID‐19: which comes first, the chicken or the egg?’
por: Anker, Markus S., et al.
Publicado: (2021)

Iron deficiency correction in heart failure patients with preserved ejection fraction: a case series study
por: Cosentino, Eugenio Roberto, et al.
Publicado: (2021)

Cardiac Medications Can Influence the Exercise Prescription in Chagas Heart Disease
por: Cunha, Raphael Martins, et al.
Publicado: (2015)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Stiff left atrial syndrome as another cause for heart failure with preserved ejection fraction and normal BNP levels
por: Lucas, C. M. H. B.
Publicado: (2016)

Assessing left ventricular systolic function with ejection fraction: using a double-edged knife as a hammer
por: Monge García, M. Ignacio, et al.
Publicado: (2019)

How to Improve the Cardiac Function and Clinical Outcomes in Patients with Heart Failure with a Mid-range Ejection Fraction
por: Imamura, Teruhiko
Publicado: (2021)

Comment on “Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective”
por: Gandjour, Afschin
Publicado: (2022)

Indeterminate Form of Chagas Disease: Some Immunological Insights
por: Matos, Daniel Mazza, et al.
Publicado: (2022)

Plasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
por: ZĂGREANU, Vasile Mircea, et al.
Publicado: (2017)

Role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020)

Dobutamine-sparing strategy in managing patients with impaired ejection fraction undergoing coronary artery bypass grafting: less is more?
por: Lin, Xiao-Ming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jft71bhdmo24si7u4qeuuscodt